Gated SPECT imaging to detect changes in myocardial blood flow during progressive coronary occlusion

International Journal of Cardiovascular Imaging

Volumn 24, Issue 3, 2008, Pages 269-276

  Christian, Timothy F ^a,b   Peters, Kevin ^c   Keck, Bradly ^c   Allen, Jill ^a   Owens, Thomas ^a   Borah, Babul ^c  

^a MAYO CLINIC   (United States)

^b UNIVERSITY OF VERMONT   (United States)

^c PROCTER AND GAMBLE COMPANY   (United States)

Author keywords

Cardiac Imaging; Gated SPECT; Myocardial blood flow; Myocardial perfusion

Indexed keywords

METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; DIAGNOSTIC AGENT; RADIOPHARMACEUTICAL AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY CIRCUMFLEX BRANCH; DIAGNOSTIC ACCURACY; GATED IMAGING; HEART INFARCTION; HEART MOVEMENT; HEART MUSCLE BLOOD FLOW; HEART MUSCLE ISCHEMIA; INDWELLING CATHETER; NONHUMAN; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SWINE; THORACOTOMY; ANALYSIS OF VARIANCE; ANIMAL; CORONARY ARTERY BLOOD FLOW; DISEASE COURSE; DISEASE MODEL; METHODOLOGY; SCINTISCANNING;

ANALYSIS OF VARIANCE; ANIMALS; CORONARY CIRCULATION; CORONARY OCCLUSION; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; MYOCARDIAL INFARCTION; RADIOPHARMACEUTICALS; SWINE; TECHNETIUM TC 99M SESTAMIBI; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 45149093576     PISSN: 15695794     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10554-007-9255-3     Document Type: Article

References (32)

1. Christian TF (1999) Detecting the effects of angiogenic therapy: How do we measure efficacy? Curr Interv Cardiol Rep 1:310-321
2. Dakik HA, Kleiman NS, Farmer JA et al (1998) Intensive medical therapyversus coronary angioplasty for suppression of myocardial ischemia insurvivors of acute myocardial infarction:a prospective, randomized pilot study. Circulation 98:2017-2023
3. Berman DS, Kang X, Schisterman EF, Gerlach J, Kavanagh PB, Areeda JS, Sharir T, Hayes SW, Shaw LJ, Lewin HC, Friedman JD, Miranda R, Germano G (2001) Serial changes on quantitative myocardial perfusion SPECT in patients undergoing revascularization or conservative therapy. J Nucl Cardiol 8(4):428-437
4. Christian TF (2006) Positively magnetic north. J Am Coll Cardiol 47:1646-1648
5. Henry TD, Annex BH, Azrin MA (1999) Double blind placebo controlled trial of recombinant human vascular endothelial growth factor - the VIVA trial. JACC 33:38A (Abstract)
6. Hendel RC, Henry TD, Rocha-Singh K, Isner JM, Kereiakes DJ, Giordano FJ, Simons M, Bonow RO (2000) Effect of intracoronary recombinant human vascular endothelial growth factor on myocardial perfusion: Evidence for a dose dependent effect. Circulation 101:118-121
7. Vale PR, Losardo DW, Milleken CE, Maysky M, Esakof DD, Symes JF, Isner JM (2000) Left ventricular electromechanical mapping to assess efficacy of ph VEGF-165 gene transfer for therapeutic angiogenesis in chronic myocardial ischemia. Circulation 102:965-974
8. Udelson JE, Dilsizian V, Laham RJ, Chronos N, Vansant J, Blais M, Galt JR, Pike M, Yoshizawa C, Simons M (2000) Therapeutic angiogenesis with recombinant fibroblast growth factor-2 improves stress and rest myocardial perfusion abnormalities in patients with severe symptomatic chronic coronary artery disease. Circulation 102:1605-1610
9. Simons M, Bonow RO, Chronos NA, Cohen DJ, Giordano FJ, Hammond HK, Laham RJ, Li W, Pike M, Sellke FW, Stegmann TJ, Udelson JE, Rosengart TK (2000) Clinical trials in coronary angiogenesis: Issues, problems, consensus: An expert panel summary. Circulation 102(11):E73-86
10. Harada K, Friedman M, Lopez JJ et al (1996) Vascular endothelial growth factor administration in chronic myocardial ischemia. Am J Physiol 270(5 Pt 2):H1791-802
11. Beanlands R, Muzik O, Nguyen N, Petry N, Schwaiger M (1992) The relationship between myocardial retention of technetium-99m teboroxime and myocardial blood flow. J Am Coll Cardiol 20(3):712-719
12. Piwnica-Worms D, Kronauge JF, Chiu ML (1990) Uptake and retention of hexakis (2-methoxyisobutyl isonitrile) technetium(I) in cultured chick myocardial cells. Mitochondrial and plasma membrane potential dependence. Circulation 82(5):1826-1838
13. Chareonthaitawee P, O'Connor MK, Gibbons RJ, Ritman EL, Christian TF (2000) The effect of collateral flow and myocardial viability on the distribution of tc-99m sestamibi in a closed chest model of coronary occlusion and reperfusion. Eur J Nucl Med 27:508-516
14. Christian TF, O'Connor MK, Schwartz RS, Gibbons RJ, Ritman EL (1997) Technetium-99m MIBI to assess coronary collateral flow during acute myocardial infarction in two closed-chest animal models. J Nuc Med 38:1840-1846
15. Prinzen FW, Bassingthwaighte JB (2000) Blood flow distributions by microsphere deposition methods. Cardiovasc Res 45:13-21
16. Domenech RJ, Hoffman JIE, Noble MIM, Saunders KB, Henson JR, Subijanto S (1969) Total and regional coronary blood flow measured by radioactive microsphere in conscious and anesthetized dogs. Circ Res 25:581-596
17. Kane GC, Hauser MF, Behrenbeck T, Miller TD, Gibbons RJ, Christian TF (2002) The impact of gender on Tc-99m sestamibi gated left ventricular ejection fraction. Am J Cardiol 89:1238-1241
18. Christian TF, Schwartz RS, Gibbons RJ (1992) Determinants of infarct size in reperfusion therapy for acute myocardial infarction. Circulation 96:81-90
19. Rosengart TK, Lee LY, Patel SR, Sanborn TA, Parikh M, Bergman GW, Hachamovitch R, Szulc M, Kligfield PD, Okin PM, Hahn RT, Devereaux RB, Post MR, Hackett NR, Foster T, Grasso TM, Lesser ML, Isom W, Crystal RG (1999) Angiogenesis gene therapy: Phase 1 assessment of direct intramyocardial administration of an adenovirus vector expression VEGF 121 c DNA to individuals with clinically significant severe coronary artery disease. Circulation 100:468-474
20. White FC, Carroll SM, Magnet A, Bloor CM (1992) Coronary collateral development in swine after coronary artery occlusion. Circ Res 71:1490-1500
21. Zhang D, Luyue GAI, Fan R, Dong W, Wen Y (2002) Efficacy and safety of therapeutic angiogenesis from direct myocardial administration of an adenoviral vector expressing vascular endothelial growth factor 165. Chin Med J 115(2):643-648
22. Lopez JJ, Edelman ER, Stamler A, Hibberd M, Prasad P, Caputo RP, Carrozza JP, Douglas PS, Sellke FW Simons M (1997) Basic fibroblast growth factor in a porcine model of chronic myocardial ischemia: A comparison of angiographic, echocardiographic and coronary flow parameters. J Pharmacol Exp Ther 282(1):385-390
23. Sato K, Laham RJ, Pearlman JD, Novicki D, Sellke FW, Simons M Post MJ (2000) Efficacy of intracoronary versus intravenous FGF-2 in a pig model of chronic myocardial ischemia Ann Thorac Surg 70:2113-2118
24. Tse HF, Kwong YL, Chan JFK, Lo G, Ho CL, Lau CP (2003) Angiogenesis in ischemic myocardium by intramyocardial autologous bone marrow mononuclear cell implantation. Lancet 361:47-49
25. Villanueva FS, Abraham JA, Schreiner GF, Csikari M, Fischer D, Mills JD, Schellenberger U, Koci BJ, Lee JS (2002) Myocardial contrast echocardiography can be used to assess the microvascular response to vascular endothelial growth factor-121. Circulation 105(6):759-765
26. Horvath KA, Doukas J, Lu CY, Belkind N, Greene R, Pierce GF, Fullerton DA (2002) Myocardial functional recovery after fibroblast growth factor 2 gene therapy as assessed by echocardiography and magnetic resonance imaging. Ann Thorac Surg 74(2):481-486
27. Lopez JJ, Laham RJ, Stamler A et al (1998) VEGF administration in chronic myocardial ischemia in pigs. Cardiovasc Res 40(2):272-281 Harada K, Friedman M, Lopez JJ et al (1996) Vascular endothelial growth factor administration in chronic myocardial ischemia. Am J Physiol 270(5 Pt 2):H1791-802
28. Hariawala MD, Horowitz JR, Esakof D et al (1996) VEGF improves myocardial blood flow but produces EDRF-mediated hypotension in porcine hearts. J Surg Res 63:77-82
29. Zohlnhofer D, Ott I, Mehilli J, Schomig K, Michalk F, Ibrahim T, Meisetschlager G, von Wedel J, Bollwein H, Seyfarth M, Dirschinger J, Schmitt C, Schwaiger M, Kastrati A, Schomig A (2006) REVIVAL-2 Investigators. Stem cell mobilization by granulocyte colony-stimulating factor in patients with acute myocardial infarction: A randomized controlled trial. JAMA 295(9):1003-1110
30. Kim BO, Tian H, Prasongsukarn K, Wu J, Angoulvant D, Wnendt S, Muhs A, Spitkovsky D, Li RK (2005) Cell transplantation improves ventricular function after a myocardial infarction: A preclinical study of human unrestricted somatic stem cells in a porcine model. Circulation 112(9 Suppl):I96-104
31. Lim SY, Kim YS, Ahn Y, Jeong MH, Hong MH, Joo SY, Nam KI, Cho JG, Kang PM, Park JC (2006) The effects of mesenchymal stem cells transduced with Akt in a porcine myocardial infarction model. Cardiovasc Res 70(3):530-542
32. Yves GCJ, Bax JJ, Dibbets-Schneider P, Pauwels EKJ, Van Der Wall EE (2004) Evaluation of the Quantitative Gated SPECT (QGS) software program in the presence of large perfusion defects. Int J Cardiovasc Imaging 21:519-529